Can America Win The AI Biotech Race Against China? | Lada Nuzhna & Elliot Hershberg
Episode
62 min
Read time
2 min
Topics
Artificial Intelligence
AI-Generated Summary
Key Takeaways
- ✓Can America compete with China's speed and cost advantages?
- ✓Will AI meaningfully reduce drug development costs and timelines?
- ✓What structural changes could revive biotech investment returns?
- ✓Where will the next trillion-dollar biotech companies emerge?
What It Covers
Lada Nuzhna and Elliot Hershberg analyze American biotech's competitive disadvantage against China, exploring regulatory barriers, AI's potential impact, and aging research opportunities.
Key Questions Answered
- •Can America compete with China's speed and cost advantages?
- •Will AI meaningfully reduce drug development costs and timelines?
- •What structural changes could revive biotech investment returns?
- •Where will the next trillion-dollar biotech companies emerge?
Notable Moment
Nuzhna reveals that George Yancopoulos paid ten thousand dollars per patient in Regeneron trials, while current costs have ballooned to five hundred thousand dollars per patient.
You just read a 3-minute summary of a 59-minute episode.
Get a16z Podcast summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from a16z Podcast
Workday’s Last Workday? AI and the Future of Enterprise Software
Apr 30 · 29 min
The TWIML AI Podcast
How to Engineer AI Inference Systems with Philip Kiely - #766
Apr 30
More from a16z Podcast
The Shift in Global Drug Development
Apr 29 · 57 min
Eye on AI
#341 Celia Merzbacher: Beyond the Buzzword: The Real State of Quantum Computing, Sensing, and AI in 2025
Apr 30
More from a16z Podcast
We summarize every new episode. Want them in your inbox?
Workday’s Last Workday? AI and the Future of Enterprise Software
The Shift in Global Drug Development
John and Patrick Collison on Stripe's Growth, Agent Commerce, and the Future of Software
Ben Horowitz on Venture Capital and AI
AI Inside the Enterprise
Similar Episodes
Related episodes from other podcasts
The TWIML AI Podcast
Apr 30
How to Engineer AI Inference Systems with Philip Kiely - #766
Eye on AI
Apr 30
#341 Celia Merzbacher: Beyond the Buzzword: The Real State of Quantum Computing, Sensing, and AI in 2025
Moonshots with Peter Diamandis
Apr 30
Google Invests $40B Into Anthropic, GPT 5.5 Drops, and Google Cloud Dominates | EP #252
Citeline Podcasts
Apr 30
Carna Health On Closing the Gap in CKD Prevention
Alt Goes Mainstream
Apr 30
Lincoln International's Brian Garfield - how is AI impacting private markets valuations?
Explore Related Topics
This podcast is featured in Best Business Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's AI & Machine Learning Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into a16z Podcast.
Every Monday, we deliver AI summaries of the latest episodes from a16z Podcast and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime